Long-term vemurafenib therapy in advanced melanoma patients: cutaneous toxicity and prognostic implications.

Among long-term survivors, skin AEs seem to be less frequent and less severe. Results on multivariable analysis revealed that the presence of at least one G2 toxicity is a protective factor considering PFS, but not in terms of OS.